Flupenthixol Treatment in Schizophrenic Cocaine Abusers - 1

National Institutes of Health (NIH) logo

National Institutes of Health (NIH)

Status and phase

Completed
Phase 2

Conditions

Cocaine-Related Disorders

Treatments

Drug: Flupenthixol

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT00000266
NIDA-09236-1
P50-09236-1

Details and patient eligibility

About

The purpose of this study is to evaluate the safety and efficacy of flupenthixol for cocaine dependence in individuals with schizophrenia/schizoaffective illness.

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems